![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
A61K 31/519 |
(11) | Number of the document | 2194058 |
(13) | Kind of document | T |
(96) | European patent application number | 10152446.0 |
Date of filing the European patent application | 2003-09-03 | |
(97) | Date of publication of the European application | 2010-06-09 |
(45) | Date of publication and mention of the grant of the patent | 2013-11-27 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
408027 P | 2002-09-04 | US | |
421959 P | 2002-10-29 | US |
(72) |
Guzi, Timothy J., US
Paruch, Kamil, CZ
Dwyer, Michael P., US
Doll, Ronald J., US
Girijavallabhan, Viyyoor M., US
Mallams, Alan K., US
Alvarez, Carmen S., US
Keertikar, Kartik M., US
Rivera, Jocelyn D., US
Chan, Tin-Yau, US
Madison, Vincent, US
Fischmann, Thierry O., US
Dillard, Lawrence W., US
Tran, Vinh D., US
He, Zhen Min, US
James, Ray Anthony, US
Park, Haengsoon, US
Paradkar, Vidyadhar M., US
Hobbs, Douglas Walsh, US
|
(73) |
Pharmacopeia, LLC,
10275 Science Center Drive, San Diego, CA 92121,
US
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
(54) | Pyrazolopyrimidines suitable for the treatment of cancer diseases |
Pyrazolopyrimidines suitable for the treatment of cancer diseases |